An effective PIKFYVE degrader molecule was developed termed PIK5-12d that strongly bind and degrades PIKFYVE protein (DC50 = 1.5 nM) and outperformed both apilimod and YM201636 in suppressing prostate cancer cells growth both in vitro and in vivo. Here, PIKFYVE is linked to prostate cancer.